Effect of Chitosan on the Quality of Gastric Ulcer Healing: An Experimental Study

Xiaobai GUO,Yong XIE,Nanjin ZHOU,Jiang CHEN
DOI: https://doi.org/10.3969/j.issn.1008-7125.2007.03.006
2007-01-01
Abstract:Background: Peptic ulcer is a common recurrent disease clinically. The ulcer recurrence is closely related to the quality of ulcer healing (QOUH). Aims: To investigate the effect of chitosan on QOUH of gastric ulcer in rats and its possible mechanism. Methods: The rats were randomly divided into placebo group, two drug-control groups (sucralfate and ranitidine), and three experimental groups (chitosan, chitosan with sucralfate and chitosan with ranitidine). After 14 days treatment, the gastric ulcer tissues were collected to examine the size and surface area of the ulcer, and stained with HE, AB-PAS, factor VII and SP immunohistochemical methods. A series of histological parameters and the expression of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and inducible nitric oxide synthase (iNOS) were detected. Results: In the experimental groups, the size of the ulcer decreased significantly more than that in the placebo and drug-control groups (P<0.01); the regenerated mucosal thickness, layers of glands, PAS-positive area and the number of microvessels in the granulation tissues increased remarkably than those in the placebo group (P<0.01), but the number of cystically dilated glands decreased (P<0.01). In the chitosan with sucralfate or with ranitidine groups, the number of cystically dilated glands was significantly lower than that in the ranitidine group (P<0.05), while PAS-positive area and the number of microvessels were higher (P<0.05); the layers of glands were significantly greater than that in the chitosan, sucralfate or ranitidine groups (P<0.05). The expression of EGF and bFGF in the three experimental groups were significantly higher than those in the placebo and ranitidine groups (P<0.05), while no significant difference was found in the expression of iNOS among all the groups. Conclusions: Chitosan can improve the QOUH of gastric ulcer in rats. Its mechanism maybe due to the increase of EGF, bFGF expression and the angiogenesis in the granulation tissues. Chitosan has synergistic effect with sucralfate and ranitidine in promoting QOUH.
What problem does this paper attempt to address?